All Stories

  1. Pretreatment with an anti-CGRP monoclonal antibody attenuates mild TBI-induced tactile hypersensitivity in mice
  2. Interplay between cannabinoids and the neuroimmune system in migraine
  3. Shared and independent roles of CGRP and PACAP in migraine pathophysiology
  4. CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
  5. Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale
  6. Editorial: Calcitonin Gene-Related Peptide: Novel Biology and Treatments
  7. CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons
  8. The voltage-gated Ca2+ channel subunit α2δ-4 regulates locomotor behavior and sensorimotor gating in mice
  9. CGRP Administration into the Cerebellum Evokes Migraine-like Behaviors Predominately in Female Mice
  10. The voltage-gated Cav Ca2+ channel subunit α2δ-4 is required for locomotor behavior and sensorimotor gating in mice
  11. Automated detection of squint as a sensitive assay of sex-dependent calcitonin gene–related peptide and amylin-induced pain in mice
  12. Investigating Migraine-Like Behavior using Light Aversion in Mice
  13. CGRP induces migraine-like symptoms in mice during both the active and inactive phases
  14. Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor
  15. Female mice exhibit a more sensitive automated squint response to pain induced by CGRP and amylin
  16. PACAP Induces Light Aversion in Mice by an Inheritable Mechanism Independent of CGRP
  17. Amylin Analog Pramlintide Induces Migraine‐like Attacks in Patients
  18. Different forms of traumatic brain injuries cause different tactile hypersensitivity profiles
  19. A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine
  20. PACAP induces light aversion in mice by an inheritable mechanism independent of CGRP
  21. Vascular actions of peripheral CGRP in migraine-like photophobia in mice
  22. Stimulation of Posterior Thalamic Nuclei Induces Photophobic Behavior in Mice
  23. Patients With Vestibular Migraine are More Likely to Have Occipital Headaches than those With Migraine Without Vestibular Symptoms
  24. Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators
  25. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting
  26. Behavioral and cognitive animal models in headache research
  27. CGRP-Based Migraine Therapeutics: How Might They Work, Why So Safe, and What Next?
  28. Vascular Contributions to Migraine: Time to Revisit?
  29. Current understanding of trigeminal ganglion structure and function in headache
  30. Peripherally administered calcitonin gene–related peptide induces spontaneous pain in mice: implications for migraine
  31. Cortical spreading depression as a site of origin for migraine: Role of CGRP
  32. Increased receptor activity-modifying protein 1 in the nervous system is sufficient to protect against autonomic dysregulation and hypertension
  33. CGRP in Animal Models of Migraine
  34. CGRP in the 21st century: A well-aged and blended peptide
  35. Anti-CGRP antibodies block CGRP-induced diarrhea in mice
  36. Lessons Learned from CGRP Mutant Mice
  37. Overview of Neuropeptides: Awakening the Senses?
  38. CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1
  39. CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured
  40. Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms
  41. Induction of calcitonin gene-related peptide expression in rats by cortical spreading depression
  42. CGRP as a neuropeptide in migraine: lessons from mice
  43. CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice
  44. CGRP receptors and migraine
  45. Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
  46. Photophobia and Abnormally Sustained Pupil Responses in a Mouse Model of Bradyopsia
  47. Heat Hyperalgesia and Mechanical Hypersensitivity Induced by Calcitonin Gene-Related Peptide in a Mouse Model of Neurofibromatosis
  48. Migraine meets membrane trafficking
  49. Reactive Oxygen Species Induce Procalcitonin Expression in Trigeminal Ganglia Glia
  50. CGRP and migraine: Could PACAP play a role too?
  51. Unanswered Questions in Headache: So What Is Photophobia, Anyway?
  52. Amylin Acts in the Central Nervous System to Increase Sympathetic Nerve Activity
  53. Protein Inhibitors of Activated STAT (Pias1 and Piasy) Differentially Regulate Pituitary Homeobox 2 (PITX2) Transcriptional Activity
  54. Modulation of CGRP-Induced Light Aversion in Wild-Type Mice by a 5-HT1B/DAgonist
  55. Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation
  56. CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice
  57. Serotonin, NO, and CGRP and Headache
  58. Neuronal Receptor Activity–Modifying Protein 1 Promotes Energy Expenditure in Mice
  59. Response to Letter by Tsuda
  60. Epigenetic regulation of the calcitonin gene–related peptide gene in trigeminal glia
  61. Receptor Activity-Modifying Protein-1 Augments Cerebrovascular Responses to Calcitonin Gene-Related Peptide and Inhibits Angiotensin II-Induced Vascular Dysfunction
  62. Receptor Activity-Modifying Protein 1 Increases Baroreflex Sensitivity and Attenuates Angiotensin-Induced Hypertension
  63. Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP
  64. Light aversion in mice depends on nonimage-forming irradiance detection.
  65. Genetic Regulation of CGRP and Its Actions
  66. Genetic Enhancement of Calcitonin Gene-Related Peptide-Induced Central Sensitization to Mechanical Stimuli in Mice
  67. Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
  68. Calcitonin gene-related peptide: an update on the biology
  69. Control of the Calcitonin Gene-related Peptide Enhancer by Upstream Stimulatory Factor in Trigeminal Ganglion Neurons
  70. Ramping it Up: RAMP1 and the Implications for Migraine
  71. Sensitization of Calcitonin Gene-Related Peptide Receptors by Receptor Activity-Modifying Protein-1 in the Trigeminal Ganglion
  72. Advent of a New Generation of Antimigraine Medications
  73. CGRP receptor antagonists: A new frontier of anti-migraine medications
  74. Calcitonin Gene-Related Peptide Receptor Activation by Receptor Activity-Modifying Protein-1 Gene Transfer to Vascular Smooth Muscle Cells
  75. Nitric oxide regulation of calcitonin gene‐related peptide gene expression in rat trigeminal ganglia neurons
  76. An unusual class of PITX2 mutations in Axenfeld‐Rieger syndrome
  77. Tumor necrosis factor‐α stimulation of calcitonin gene‐related peptide expression and secretion from rat trigeminal ganglion neurons
  78. Vitamin D Control of the Calcitonin Gene in Thyroid C Cells
  79. Cell-specific Activation of the Atrial Natriuretic Factor Promoter by PITX2 and MEF2A
  80. Regulation of the Cell-specific Calcitonin/Calcitonin Gene-related Peptide Enhancer by USF and the Foxa2 Forkhead Protein
  81. Analysis of two translocation breakpoints and identification of a negative regulatory element in patients with Rieger's syndrome
  82. Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons
  83. Dominant Negative Dimerization of a Mutant Homeodomain Protein in Axenfeld-Rieger Syndrome
  84. Calcium Receptor-Induced Serotonin Secretion by Parafollicular Cells: Role of Phosphatidylinositol 3-Kinase-Dependent Signal Transduction Pathways
  85. Homeobox Protein, Hmx3, in Postnatally Developing Rat Submandibular Glands
  86. Stimulation of the Calcitonin Gene-Related Peptide Enhancer by Mitogen-Activated Protein Kinases and Repression by an Antimigraine Drug in Trigeminal Ganglia Neurons
  87. NCS-1 Inhibits Insulin-stimulated GLUT4 Translocation in 3T3L1 Adipocytes through a Phosphatidylinositol 4-Kinase-dependent Pathway
  88. New insights into the molecular actions of serotonergic antimigraine drugs
  89. Antagonistic Regulation of <I>Dlx2</I> Expression by PITX2 and Msx2: Implications for Tooth Development
  90. Autoregulation of Cell-specific MAP Kinase Control of the Tryptophan Hydroxylase Promoter
  91. Identification of a Dominant Negative Homeodomain Mutation in Rieger Syndrome
  92. Developmental regulation of tryptophan hydroxylase messenger RNA expression and enzyme activity in the raphe and its target fields
  93. Differential Regulation of Mitogen-Activated Protein Kinase-Responsive Genes by the Duration of a Calcium Signal
  94. Gene transfer of calcitonin gene-related peptide to cerebral arteries
  95. Multifunctional Role of the Pitx2 Homeodomain Protein C-Terminal Tail
  96. Regulation of Calcitonin Gene-Related Peptide Secretion by a Serotonergic Antimigraine Drug
  97. Transcriptional Antagonism between Hmx1 and Nkx2.5 for a Shared DNA-binding Site
  98. The Molecular Basis of Rieger Syndrome
  99. Serotonergic Repression of Mitogen-Activated Protein Kinase Control of the Calcitonin Gene-Related Peptide Enhancer
  100. Measurement of tryptophan hydroxylase mRNA levels by competitive RT-PCR
  101. BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain
  102. Requirement of the MASH-1 transcription factor for neuroendocrine differentiation of thyroid C cells
  103. Repression of the Calcitonin Gene-Related Peptide Promoter by 5-HT1Receptor Activation
  104. Tissue-specific glucocorticoid regulation of tryptophan hydroxylase mRNA levels
  105. Binding of Upstream Stimulatory Factor and a Cell-specific Activator to the Calcitonin/Calcitonin Gene-related Peptide Enhancer
  106. Thyroid parafollicular cells
  107. Expression and development of a functional plasmalemmal 5-hydroxytryptamine transporter by thyroid follicular cells.
  108. Induction of a serotonergic and neuronal phenotype in thyroid C-cells
  109. Serotonergic Neuronal Properties in C-Cell Lines
  110. Retinoic acid repression of cell-specific helix-loop-helix-octamer activation of the calcitonin/calcitonin gene-related peptide enhancer.
  111. Retinoic acid is enriched in Hensen's node and is developmentally regulated in the early chicken embryo.
  112. A rapid PCR protocol for identification of differentially expressed genes from a cDNA library.
  113. Neuronal properties of a thyroid C-cell line: partial repression by dexamethasone and retinoic acid.
  114. Characterization of the calcitonin/CGRP gene in Williams syndrome
  115. Isolation of cDNA clones encoding small nuclear ribonucleoparticle-associated proteins with different tissue specificities.
  116. Neuronal Expression of chimeric genes in transgenic mice
  117. Molecular cloning of a brain-specific calcium/calmodulin-dependent protein kinase.
  118. Neuron-specific alternative RNA processing in transgenic mice expressing a metallothionein-calcitonin fusion gene
  119. Neuron-specific alternative RNA processing in neuroendocrine gene expression
  120. Identification of the tip-encoded receptor in bacterial sensing
  121. Role of Silicon in Diatom Metabolism
  122. Separation of Signal Transduction and Adaptation Functions of the Aspartate Receptor in Bacterial Sensing
  123. Information Processing in a Sensory System